title: Influence of dissolution medium agitation on release profiles of sustained-release tablets.
abstract: Reaching nearly perfect sink conditions is very important in the determination of drug dissolution rates. Many times, the only factor that is taken into consideration in achieving sink conditions is the relation between the drug concentration and its solubility. The analytical conditions of the dissolution assay, as well as the dissolution apparatus, stirring speed, and nature and volume of the dissolution fluid may also influence the dissolution results. The main objective of this work was to study the influence of the stirring rate conditions and of the dissolution apparatus in the diltiazem hydrochloride release from tablets. Diltiazem hydrochloride sustained-release (SR) tablets were tested and the follow ing dissolution parameters were evaluated: t10%, t25%, t50%, dissolution time, mean dissolution time (MDT), and dissolution efficiency (DE) at t120, and at t360. To analyze the release mechanism, several release models were tested, such as Higuchi, zero order, first order, Baker-Lonsdale, Hixson-Crowell, Weibull, and Korsmeyer-Peppas. The similarities between two in vitro dissolution profiles were assessed by the similarity factor f2. The in vitro release kinetics of diltiazem hydrochloride sustained-release tablets were evaluated using the USP 2 (paddle) and USP 4 (flow-through) apparatus.
authors.affiliation: Centro de Teconologia do Medicamento, Faculdade de Farmácia, Universidade do Porto, Portugal.
authors.lastname: Paulo
authors.forename: J M
authors.initials: JM
authors.lastname: Sousa Lobo
mesh_terms: D000465:Algorithms; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D003692:Delayed-Action Preparations / Q000737:chemistry*; D004110:Diltiazem / Q000008:administration & dosage / Q000737:chemistry; D006244:Hardness; D012995:Solubility; D012997:Solvents; D013607:Tablets
chemical_list: D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations; D012997:Solvents; D013607:Tablets; D004110:Diltiazem